Profiel
David O'Neill currently works at Triphase Accelerator Corp., as Director from 2018.
Dr. O'Neill also formerly worked at Fight Against Cancer Innovation Trust, as President from 2017 to 2025.
Dr. O'Neill received his graduate degree from the University of Western Ontario.
Actieve functies van David O'Neill
| Bedrijven | Functie | Begin |
|---|---|---|
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Directeur/Bestuurslid | 01-01-2018 |
Eerdere bekende functies van David O'Neill
| Bedrijven | Functie | Einde |
|---|---|---|
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust invests in companies located in Canada, primarily in Ontario. The firm targets companies operating in the fields of technology, therapeutics, imaging and diagnostics sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 5 million. It also makes follow-on investments. | Private Equity Investor | 06-01-2025 |
Opleiding van David O'Neill
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust invests in companies located in Canada, primarily in Ontario. The firm targets companies operating in the fields of technology, therapeutics, imaging and diagnostics sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 5 million. It also makes follow-on investments. | Finance |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Health Technology |
















